Ignite Creation Date:
2025-12-24 @ 4:37 PM
Ignite Modification Date:
2026-01-25 @ 11:56 PM
Study NCT ID:
NCT01245166
Status:
UNKNOWN
Last Update Posted:
2010-11-22
First Post:
2010-11-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase III Randomized, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg Plus Acarbose 50 mg Tablets) Versus Acarbose Alone in Subjects With Type 2 Diabetes Mellitus
Sponsor:
Lotus Pharmaceutical
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MCCD09013B
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Dr. Wayne-Huey-Herng Sheu
Old Organization:
Taichung Veterans General Hospital